LEARN MORE

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.

LEARN MORE

Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

Marinus Pharma's Twitter avatar
Marinus Pharma
@MarinusPharma

By reducing the uptake of neurotransmitters, ganaxolone “tones down” brain activity. This has a therapeutic effect… t.co/WdZZYY8tei